Skip to content
Have We Learned How to Talk About GLP1s? episode artwork

Apr 28, 2026 54 min

Have We Learned How to Talk About GLP1s?

from KQED's Forum Hosted by KQED

An estimated one in eight Americans has now tried a GLP-1 medication like Ozempic or WeGovy: to lose weight, manage diabetes or experiment with anecdotal, off-label benefits. Yet GLP-1s can be hard to talk about — whether you want to ask someone if they take one, respond if you do, or discuss weight without dredging up unhealthy diet discourse. We’ll hear how you’re navigating these conversations in the age of GLP-1s. Tell us: How are GLP-1s showing up in your world? Guests: Diana Thiara, medical director, UCSF Weight Loss Management Program Whitney Casares, pediatrician; author, “Raising Body-Confident Kids” and “My One-Of A-Kind Body: The Ultimate Guide to Caring for Me” Angela Corral, senior editor, KQED’s The California Report; she has been been taking a GLP-1 for almost 2 years

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Have We Learned How to Talk About GLP1s?

0:00 54:46

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of KQED's Forum?

This episode is 54 minutes long.

When was this KQED's Forum episode published?

This episode was published on April 28, 2026.

Can I download this KQED's Forum episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.